PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

MACOP-B protocol

Subscribe to Selected New Research on MACOP-B protocol

4 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: chemotherapy protocol consisting of above cpds; used in treatment of large cell and immunoblastic lymphomas

Also Known As:

MECOP-B PROTOCOL; TTL-I protocol

Bio-Agent Context: Research Results

-

Therapeutics: 5215

-

Drug Therapy: 116820

-

Combination Drug Therapy: 8327

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

MACOP-B protocol: 4

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

MACOP-B protocol: 4

-

Clinical Protocols

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

MACOP-B protocol: 4

-

Carbohydrates: 2948

-

Glycoconjugates: 631

-

Glycopeptides: 482

-

Bleomycin: 5153

*

MACOP-B protocol: 4

-

Glycosides: 341

-

Aminoglycosides: 1077

-

Anthracyclines: 1293

-

Daunorubicin: 1725

-

Doxorubicin: 15026

*

MACOP-B protocol: 4

-

Amino Acids, Peptides, and Proteins

-

Peptides: 16094

-

Glycopeptides: 482

-

Bleomycin: 5153

*

MACOP-B protocol: 4

-

Enzymes and Coenzymes: 1

-

-

Tetrahydrofolates: 7

-

Formyltetrahydrofolates

-

Leucovorin: 3353

*

MACOP-B protocol: 4

-

Polycyclic Compounds: 58

-

Steroids: 13706

-

-

-

Pregnadienediols

-

Prednisone: 7165

*

MACOP-B protocol: 4

-

Aromatic Polycyclic Hydrocarbons: 581

-

-

Anthracyclines: 1293

-

Daunorubicin: 1725

-

Doxorubicin: 15026

*

MACOP-B protocol: 4